316 related articles for article (PubMed ID: 16243818)
1. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
[TBL] [Abstract][Full Text] [Related]
2. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
Sterman DH; Molnar-Kimber K; Iyengar T; Chang M; Lanuti M; Amin KM; Pierce BK; Kang E; Treat J; Recio A; Litzky L; Wilson JM; Kaiser LR; Albelda SM
Cancer Gene Ther; 2000 Dec; 7(12):1511-8. PubMed ID: 11228529
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM
Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy.
Berlinghoff S; Veldwijk MR; Laufs S; Maser HP; Jauch A; Wenz F; Jens Zeller W; Fruehauf S
Lung Cancer; 2004 Nov; 46(2):179-86. PubMed ID: 15474666
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J
J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071
[TBL] [Abstract][Full Text] [Related]
10. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
11. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer.
Wildner O; Morris JC; Vahanian NN; Ford H; Ramsey WJ; Blaese RM
Gene Ther; 1999 Jan; 6(1):57-62. PubMed ID: 10341876
[TBL] [Abstract][Full Text] [Related]
14. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
15. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
van der Linden RR; Haagmans BL; Mongiat-Artus P; van Doornum GJ; Kraaij R; Kadmon D; Aguilar-Cordova E; Osterhaus AD; van der Kwast TH; Bangma CH
Eur Urol; 2005 Jul; 48(1):153-61. PubMed ID: 15967266
[TBL] [Abstract][Full Text] [Related]
16. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.
van der Eb MM; Cramer SJ; Vergouwe Y; Schagen FH; van Krieken JH; van der Eb AJ; Borel Rinkes IH; van de Velde CJ; Hoeben RC
Gene Ther; 1998 Apr; 5(4):451-8. PubMed ID: 9614568
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer.
Hwang HC; Smythe WR; Elshami AA; Kucharczuk JC; Amin KM; Williams JP; Litzky LA; Kaiser LR; Albelda SM
Am J Respir Cell Mol Biol; 1995 Jul; 13(1):7-16. PubMed ID: 7598939
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene.
Elshami AA; Kucharczuk JC; Zhang HB; Smythe WR; Hwang HC; Litzky LA; Kaiser LR; Albelda SM
Hum Gene Ther; 1996 Jan; 7(2):141-8. PubMed ID: 8788165
[TBL] [Abstract][Full Text] [Related]
19. Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase.
Oh JY; Park MY; Kim DR; Lee JH; Shim SH; Chung JH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
Int J Mol Med; 2010 Mar; 25(3):369-76. PubMed ID: 20127041
[TBL] [Abstract][Full Text] [Related]
20. Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro.
Yamamoto N; Hayashi Y; Kagami H; Fukui T; Fukuhara H; Tohnai I; Ueda M; Mizuno M; Yoshida J
Nagoya J Med Sci; 2005 Jun; 67(3-4):83-91. PubMed ID: 17375474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
